Galapagos announces expanded drug discovery collaboration with Schering-Plough
Building on a collaboration established in May 2009 and expanded this month, BioFocus DPI scientists will work with two of SPRI's European sites on these drug discovery projects.
"We are pleased to build on our collaborative relationship with SPRI, which has evolved into one of the larger for BioFocus DPI this year with over 20 research staff currently engaged," said Onno van de Stolpe, CEO of Galapagos. "BioFocus DPI has proven resilient in securing large collaborations with strong partners, amidst consolidation and reorganization in the pharma industry."
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.